Ocrelizumab treatment induces a sustained blood NFL reduction in patients with PPMS and RMS

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2020
This article has no abstract
Epistemonikos ID: 208f6d09cfb1e1359db3086d961f08c6e6e220fd
First added on: Apr 30, 2026